Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,259 signal articles · 40 in last 24h · 115,274 total before filter · latest 58m ago
40last 24h
1802last 7d
299● bullish (7d)
170● bearish (7d)
205publishers
AllMacro322Earnings850M&A104Regulatory25Product16Analyst25
✕ clear all filtersticker: ABBVSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm
Insider Monkey54d agobullish
AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm

AbbVie Inc. (NYSE:ABBV) is one of the 12 High Quality Stocks to Buy for the Long Term. On June 16, 2026, Allergan Aesthetics, an AbbVie Inc. (NYSE:ABBV) company, announced the U.S. FDA approval of Skinvive by Juvederm to reduce neck lines and improve neck appearance in adults over the age of 21. AbbVie said Skinvive […]